IL-10, on the one hand, can enhance the maintenance of the PD-L1/PD-1 axis, thereby promoting immune escape of tumor cells, and on the other hand, IL-10 induces up-regulation of PD-L1 expression in monocytes, thereby weakening CD8+ T cell-mediated immune surveillance. The gene discussed is CD274; the disease is neoplasm.